These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 10964076)
61. Long-term study with gabapentin in patients with drug-resistant epileptic seizures. Sivenius J; Ylinen A; Kälviäinen R; Riekkinen PJ Arch Neurol; 1994 Oct; 51(10):1047-50. PubMed ID: 7945002 [TBL] [Abstract][Full Text] [Related]
62. Gabapentin bioavailability: effect of dose and frequency of administration in adult patients with epilepsy. Gidal BE; DeCerce J; Bockbrader HN; Gonzalez J; Kruger S; Pitterle ME; Rutecki P; Ramsay RE Epilepsy Res; 1998 Jul; 31(2):91-9. PubMed ID: 9714500 [TBL] [Abstract][Full Text] [Related]
63. The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy. Wong IC; Chadwick DW; Fenwick PB; Mawer GE; Sander JW Epilepsia; 1999 Oct; 40(10):1439-45. PubMed ID: 10528941 [TBL] [Abstract][Full Text] [Related]
64. Effects of antiepileptic drugs on sleep architecture: a pilot study. Legros B; Bazil CW Sleep Med; 2003 Jan; 4(1):51-5. PubMed ID: 14592360 [TBL] [Abstract][Full Text] [Related]
66. [Gabapentin in 50 patients with epilepsy]. Gracia-Fleta F; Medrano-Martínez V; Castaño-Pérez MD; Hernández-Lorido R; Mañes R Rev Neurol; 2001 Jan 1-15; 32(1):45-9. PubMed ID: 11293098 [TBL] [Abstract][Full Text] [Related]
67. Failure of absorption of gabapentin after rectal administration. Kriel RL; Birnbaum AK; Cloyd JC; Ricker BJ; Jones Saete C; Caruso KJ Epilepsia; 1997 Nov; 38(11):1242-4. PubMed ID: 9579927 [TBL] [Abstract][Full Text] [Related]
68. Plasma gabapentin concentrations in children with epilepsy: influence of age, relationship with dosage, and preliminary observations on correlation with clinical response. Gatti G; Ferrari AR; Guerrini R; Bonanni P; Bonomi I; Perucca E Ther Drug Monit; 2003 Feb; 25(1):54-60. PubMed ID: 12548145 [TBL] [Abstract][Full Text] [Related]
69. Gabapentin and carbamazepine affect eye movements and posture control differently: a placebo-controlled investigation of acute CNS side effects in healthy volunteers. Noachtar S; von Maydell B; Fuhry L; Büttner U Epilepsy Res; 1998 Jun; 31(1):47-57. PubMed ID: 9696300 [TBL] [Abstract][Full Text] [Related]
70. Gabapentin: a new agent for the management of epilepsy. Andrews CO; Fischer JH Ann Pharmacother; 1994 Oct; 28(10):1188-96. PubMed ID: 7841578 [TBL] [Abstract][Full Text] [Related]
71. Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study. Appleton R; Fichtner K; LaMoreaux L; Alexander J; Maton S; Murray G; Garofalo E Dev Med Child Neurol; 2001 Apr; 43(4):269-73. PubMed ID: 11305405 [TBL] [Abstract][Full Text] [Related]
72. Add-on gabapentin for refractory seizures in patients with brain tumours. Perry JR; Sawka C Can J Neurol Sci; 1996 May; 23(2):128-31. PubMed ID: 8738926 [TBL] [Abstract][Full Text] [Related]
73. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83. Beydoun A; Fischer J; Labar DR; Harden C; Cantrell D; Uthman BM; Sackellares JC; Abou-Khalil B; Ramsay RE; Hayes A; Greiner M; Garofalo E; Pierce M Neurology; 1997 Sep; 49(3):746-52. PubMed ID: 9305335 [TBL] [Abstract][Full Text] [Related]
74. Seizure frequency and CSF parameters in a double-blind placebo controlled trial of gabapentin in patients with intractable complex partial seizures. Ben-Menachem E; Söderfelt B; Hamberger A; Hedner T; Persson LI Epilepsy Res; 1995 Jul; 21(3):231-6. PubMed ID: 8536677 [TBL] [Abstract][Full Text] [Related]
75. NREM Sleep and Antiepileptic Medications Modulate Epileptiform Activity by Altering Cortical Synchrony. Nayak CS; Mariyappa N; Majumdar KK; Ravi GS; Prasad PD; Nagappa M; Kandavel T; Taly AB; Sinha S Clin EEG Neurosci; 2018 Nov; 49(6):417-424. PubMed ID: 29308656 [TBL] [Abstract][Full Text] [Related]
76. Clinical efficacy and safety of gabapentin. Ramsay RE Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537 [TBL] [Abstract][Full Text] [Related]
77. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy. Goa KL; Sorkin EM Drugs; 1993 Sep; 46(3):409-427. PubMed ID: 7693432 [TBL] [Abstract][Full Text] [Related]
78. Oxcarbazepine in focal epilepsy and hepatic porphyria: a case report. Gaida-Hommernick B; Rieck K; Runge U Epilepsia; 2001 Jun; 42(6):793-5. PubMed ID: 11422339 [TBL] [Abstract][Full Text] [Related]
79. Gabapentin toxicity in children manifesting as behavioral changes. Wolf SM; Shinnar S; Kang H; Gil KB; Moshé SL Epilepsia; 1995 Dec; 36(12):1203-5. PubMed ID: 7489697 [TBL] [Abstract][Full Text] [Related]
80. [Trials with gabapentin monotherapy in patients with complex partial or secondary generalized seizures]. Pierce MW; Shokry A Praxis (Bern 1994); 1997 Sep; 86(37):1430-1. PubMed ID: 9381042 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]